Company Overview

Philip Morris International (PMI) is a leading international tobacco company, actively driving towards a smoke-free future and evolving its portfolio for the long term to encompass products beyond tobacco and nicotine. The company's current product offering primarily consists of traditional cigarettes and innovative smoke-free alternatives. Established in 2008 from the international operations of Altria, Philip Morris International markets cigarettes and reduced-risk products—including heat sticks, vapes, and oral nicotine offerings—predominantly outside the United States.

Market Position and Financial Performance

As of September 2025, Philip Morris International boasts a market capitalization of $252.13 Billion USD, positioning it as the 52nd most valuable company globally according to our data. The company has demonstrated robust financial performance. In fiscal year 2024, Philip Morris International's annual revenue reached $37.88 billion USD, an increase of $2.70 billion USD from $35.17 billion USD in 2023, representing a year-over-year growth of 7.69%.

Key Financial Metrics (2024)

- Revenue: Reported net annual revenue (excluding excise taxes) of US$37.878 billion.

- Earnings: Reported earnings of US$7.057 billion.

- Diluted EPS: Delivered 2024 Reported Diluted EPS of $4.52 (or $6.01 before a non-cash impairment of $1.49 in Canada), compared to $5.02 in 2023. Adjusted Diluted EPS grew by 9.3% to $6.57, representing 15.6% growth on a currency-neutral basis.

- Operating Income: Increased by 16.0% to $13.4 billion.

- Operating Cash Flow: Increased by 32.7% to $12.2 billion.

- Dividends: Declared a regular quarterly dividend of $1.35 per share, translating to an annualized $5.40 per share.

Smoke-Free Transformation Strategy

PMI is strategically building its future on smoke-free products, which represent a better choice compared to cigarette smoking. The company's long-term vision is for these products to eventually replace traditional cigarettes. Since 2008, PMI has invested over $14 billion USD in the development, scientific substantiation, and commercialization of innovative smoke-free products designed for adult smokers who would otherwise continue to smoke, with the ultimate goal of phasing out cigarette sales entirely.

Product Portfolio and Innovation

The company's flagship brands and product categories include:

IQOS Heat-Not-Burn Products

Launched in 2014, IQOS heated tobacco products are PMI's flagship smoke-free offering and surpassed Marlboro's net revenue by the end of 2023. Following a rigorous science-based review, the U.S. Food and Drug Administration (FDA) authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches, as well as versions of PMI's IQOS devices and consumables—marking the first-ever authorizations in their respective categories.

ZYN Nicotine Pouches

The highly anticipated U.S. FDA authorization for all ZYN nicotine pouches currently marketed in the U.S. further validates the compelling scientific evidence supporting smoke-free products. This development contributes to absolute growth in heated tobacco unit (HTU) adjusted In Market Sales (IMS) volumes at a level similar to 2024, projecting 10% to 12% growth. The HTU shipment growth rate is expected to be broadly in line, subject to shipment timing and trade inventory movements. An acceleration in U.S. nicotine pouch shipment volumes is anticipated, reaching 780 to 820 million cans, representing growth of 34% to 41%.

Traditional Cigarettes

Marlboro, launched in 1924, remains the world's best-selling cigarette brand and ranks among the most valuable tobacco brands globally.

Global Reach and Market Penetration

Philip Morris International operates in the manufacture and sale of cigarettes and smoke-free products across more than 180 markets worldwide. As of December 31, 2024, PMI's smoke-free products were available in 95 markets, and the company estimates that approximately 38.6 million adults globally use PMI's smoke-free products. The smoke-free business accounted for roughly 39% of PMI's total net revenues for the full year 2024.

Strategic Acquisitions

In 2022, PMI acquired Swedish Match, a leader in oral nicotine delivery. This strategic move created a global smoke-free champion led by PMI's IQOS and ZYN brands. The 2023 integration of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, not only diversified PMI away from smokable products but also established a foothold in the US market for selling its IQOS heated tobacco product.

Future Growth Objectives

As of 2024, approximately 40% of PMI's revenue is derived from smoke-free products. The company aims to increase this to two-thirds of revenue by 2030. While ambitious, forecasts suggest PMI will reach roughly 52% by 2029. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas, aiming to enhance lives through the delivery of seamless health experiences.

Philip Morris International represents one of the most significant transformation stories within the tobacco industry. The company is systematically transitioning from traditional cigarettes to reduced-risk products while maintaining strong financial performance and global market leadership. PMI's substantial investment in research, development, and regulatory approval processes firmly positions it as a frontrunner in the evolving tobacco and nicotine landscape.